leucine has been researched along with HIV in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, W; Lovell, S; Mensa, FJ; Pilot-Matias, T | 1 |
| Laufer, NL; Rockstroh, JK | 1 |
| Balage, M; Beytout, J; Champredon, C; Grizard, J; Laurichesse, H; Prod'homme, M; Rochon, C; Tauveron, I; Thieblot, P | 1 |
| Qiang, W; Weliky, DP; Zheng, Z | 1 |
| Borkowsky, W; Bourinbaiar, AS; Krasinski, K; Lee-Huang, S | 1 |
| Brown, R; Conway, B; Izaguirre, CA; Proulx, P; Pulido-Cejudo, G | 1 |
| Epstein, LG; Kieburtz, K; Marder, K; McArthur, JC; McDermott, MP; Sacktor, N; Schifitto, G; Small, S | 1 |
| Hardin, DS; Johnson, P; LeBlanc, A; Young, D | 1 |
2 review(s) available for leucine and HIV
| Article | Year |
|---|---|
Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Coinfection; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Fibrosis; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Lactams, Macrocyclic; Leucine; Proline; Protease Inhibitors; Pyrrolidines; Quinoxalines; Renal Insufficiency, Chronic; Sulfonamides; Treatment Outcome | 2019 |
Faldaprevir (BI 201335) for the treatment of hepatitis C in patients co-infected with HIV.
Topics: Aminoisobutyric Acids; Antiviral Agents; Biological Availability; Clinical Trials as Topic; Coinfection; Drug Administration Schedule; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Leucine; Oligopeptides; Proline; Protease Inhibitors; Quinolines; Thiazoles; Virus Replication | 2014 |
1 trial(s) available for leucine and HIV
| Article | Year |
|---|---|
Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.
Topics: Adult; Cognition Disorders; Double-Blind Method; Female; HIV; Humans; Imidazoles; Leucine; Male; Middle Aged; Neuropsychological Tests; Platelet Activating Factor | 1999 |
5 other study(ies) available for leucine and HIV
| Article | Year |
|---|---|
Whole body leucine flux in HIV-infected patients treated with or without protease inhibitors.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Body Composition; Carbon Dioxide; Glucose; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Leucine; Male; Middle Aged | 2006 |
Investigation of finite-pulse radiofrequency-driven recoupling methods for measurement of intercarbonyl distances in polycrystalline and membrane-associated HIV fusion peptide samples.
Topics: Amino Acid Sequence; Crystallization; HIV; Leucine; Magnetic Resonance Spectroscopy; Membrane Fusion; Membrane Lipids; Molecular Sequence Data; Protein Structure, Secondary; Radio Waves; Signal-To-Noise Ratio; Viral Fusion Proteins | 2007 |
Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro.
Topics: Anti-Bacterial Agents; CD4-Positive T-Lymphocytes; Cell Division; Cell-Free System; Dextran Sulfate; HIV; HIV Infections; Immunity, Cellular; Immunologic Factors; In Vitro Techniques; Leucine; Virus Replication; Zidovudine | 1994 |
Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection.
Topics: Anti-HIV Agents; Cytopathogenic Effect, Viral; HIV; HIV Core Protein p24; HIV Infections; Humans; Leucine; Leucyl Aminopeptidase; Protease Inhibitors; Protein Kinase C; Tumor Cells, Cultured | 1997 |
Increased leucine turnover and insulin resistance in men with advanced HIV infection.
Topics: Adult; Body Mass Index; Energy Metabolism; Glucose; HIV; HIV Infections; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Leucine; Liver; Male; RNA, Viral; Viral Load | 1999 |